Literature DB >> 4214014

The intravitreal use of carbenicillin (Geopen) for treatment od pseudomonas endophthalmitis.

A G Schenk, G A Peyman, J T Paque.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4214014     DOI: 10.1111/j.1755-3768.1974.tb01105.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


× No keyword cloud information.
  8 in total

1.  Prediction of the vitreal half-life of small molecular drug-like compounds.

Authors:  Heidi Kidron; Eva M Del Amo; Kati-Sisko Vellonen; Arto Urtti
Journal:  Pharm Res       Date:  2012-07-10       Impact factor: 4.200

2.  Concentration of ampicillin in the vitreous after cryocoagulation.

Authors:  H Röber; W Göring; H Sous; M Reim
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1977-12-31

3.  Toxicity and clearance of intravitreal cefotetan.

Authors:  W Philipp; K Schmid; H J Steiner; B Pümpel; F Allerberger; H P Aichberger; W Mayer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

Review 4.  Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.

Authors:  G A Stern
Journal:  Trans Am Ophthalmol Soc       Date:  1993

5.  The experimental and clinical use of intravitreal antibiotics to treat bacterial and fungal endophthalmitis.

Authors:  G A Peyman; D W Vastine; H I Meisels
Journal:  Doc Ophthalmol       Date:  1975-11-21       Impact factor: 2.379

6.  Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.

Authors:  T A Meredith
Journal:  Trans Am Ophthalmol Soc       Date:  1993

7.  Retinal toxicity of antibiotics: evaluation by electroretinogram.

Authors:  K Mochizuki; M Torisaki; K Kawasaki; Y Shirao; Y Yamashita; K Kitano; D Yonemura
Journal:  Doc Ophthalmol       Date:  1988-06       Impact factor: 2.379

8.  Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR).

Authors:  Chandrasekar Durairaj; Jaymin C Shah; Shruti Senapati; Uday B Kompella
Journal:  Pharm Res       Date:  2008-10-08       Impact factor: 4.200

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.